Related Experiment Videos

[Gammagraphy with labeled leukocytes as an activity and extension index of Crohn disease]

F Sopeña1, J M Nerin, E Prats

  • 1Servicio de Aparato Digestivo, Hospital Clínico Universitario, Zaragoza.

Insights

Technetium-99m-HMPAO labeled leukocyte scintigraphy is a highly sensitive and specific tool for evaluating Crohn

Area of Science:

  • Gastroenterology and Nuclear Medicine

Background:

  • Assessing bowel involvement and disease activity is crucial for managing inflammatory bowel disease (IBD).
  • Crohn's disease (CD) requires accurate methods to determine the location, extent, and activity of inflammation.

Purpose of the Study:

  • To evaluate the utility of 99mTc-HMPAO labeled leukocyte scintigraphy in assessing Crohn's disease activity and extent.
  • To compare the diagnostic performance of leukocyte scanning with clinical, biological, radiological, and endoscopic findings.

Main Methods:

  • Thirty-five patients with Crohn's disease underwent 44 scintigraphic examinations using 99mTc-HMPAO labeled leukocytes.
  • Results were compared with clinical-biological indices, radiology, and endoscopy.

Main Results:

  • Leukocyte scintigraphy demonstrated high sensitivity (84.3%) and specificity (100%) for detecting disease activity.
  • The technique showed excellent correlation with radiology and/or endoscopy in assessing the extent of Crohn's disease.
  • Leukocyte scanning provided valuable information for managing stenosis in CD patients.

Conclusions:

  • 99mTc-HMPAO labeled leukocyte scintigraphy is a sensitive and specific imaging modality for evaluating Crohn's disease.
  • This method aids in assessing disease extent and activity, correlating well with established diagnostic tools.
  • Leukocyte scanning offers valuable insights for the management of complications like stenosis in Crohn's disease.

Related Concept Videos